Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: Role of signal transducer and activator of transcription 3

Human Pathology

Volumn 42, Issue 12, 2011, Pages 1989-2000

  Badoux, Xavier ^a   Bueso Ramos, Carlos ^a   Harris, David ^a   Li, Ping ^a   Liu, Zhiming ^a   Burger, Jan ^a   O'Brien, Susan ^a   Ferrajoli, Alessandra ^a   Keating, Michael J ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

CLL; Endothelial cells; STAT3; Stroma; VEGF

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL ADHESION; CELL DENSITY; CELL INTERACTION; CELL PROTECTION; CHROMATIN IMMUNOPRECIPITATION; CHRONIC LYMPHATIC LEUKEMIA; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE COUNT; MOLECULAR INTERACTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; BONE MARROW; BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80955133848     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.02.027     Document Type: Article

References (41)

1. J.A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio The microenvironment in mature B-cell malignancies: a target for new treatment strategies Blood 114 2009 3367 3375
2. H. Chen, A.T. Treweeke, and D.C. West In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells Blood 96 2000 3181 3187
3. A.R. Kini, N.E. Kay, and L.C. Peterson Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia Leukemia 14 2000 1414 1418 (Pubitemid 30599322)
4. S. Molica, A. Vacca, and D. Ribatti Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia Blood 100 2002 3344 3351 (Pubitemid 35217086)
5. L. Peterson, and A.R. Kini Angiogenesis is increased in B-cell chronic lymphocytic leukemia Blood 97 2001 2529 (Pubitemid 32291507)
6. A. Aguayo, S. O'Brien, and M. Keating Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia Blood 96 2000 768 770 (Pubitemid 30463404)
7. S. Molica, R. Santoro, G. Digiesi, A. Dattilo, D. Levato, and G. Muleo Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells Haematologica 85 2000 1106 1108
8. N.E. Kay, N.D. Bone, and R.C. Tschumper B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules Leukemia 16 2002 911 919 (Pubitemid 34537565)
9. S. Molica, G. Vitelli, D. Levato, A. Ricciotti, and G. Digiesi Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia Br J Cancer 86 2002 31 35 (Pubitemid 34146337)
10. S. Molica, G. Vitelli, D. Levato, G.M. Gandolfo, and V. Liso Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia Br J Haematol 107 1999 605 610
11. O. Bairey, O. Boycov, E. Kaganovsky, Y. Zimra, M. Shaklai, and E. Rabizadeh All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells Leuk Res 28 2004 243 248 (Pubitemid 37550058)
12. A. Aguayo, T. Manshouri, and S. O'Brien Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL) Leuk Res 25 2001 279 285 (Pubitemid 32184587)
13. A. Ferrajoli, T. Manshouri, and Z. Estrov High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia Clin Cancer Res 7 2001 795 799 (Pubitemid 32708712)
14. T.S. Lin, S. Mahajan, and D.A. Frank STAT signaling in the pathogenesis and treatment of leukemias Oncogene 19 2000 2496 2504 (Pubitemid 30339205)
15. J. Bromberg, and J.E. Darnell Jr The role of STATs in transcriptional control and their impact on cellular function Oncogene 19 2000 2468 2473 (Pubitemid 30339202)
16. C.L. Yu, R. Jove, and S.J. Burakoff Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase J Immunol 159 1997 5206 5210 (Pubitemid 127470045)
17. Q. Zhang, P.N. Raghunath, and L. Xue Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma J Immunol 168 2002 466 474 (Pubitemid 34014150)
18. D.A. Frank, S. Mahajan, and J. Ritz B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues J Clin Invest 100 1997 3140 3148 (Pubitemid 28022852)
19. I. Hazan-Halevy, D. Harris, and Z. Liu STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells Blood 115 2010 2852 2863
20. G. Niu, K.L. Wright, and M. Huang Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008 (Pubitemid 34270888)
21. D. Wei, X. Le, and L. Zheng Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis Oncogene 22 2003 319 329 (Pubitemid 36194328)
22. Q. Xu, J. Briggs, and S. Park Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Oncogene 24 2005 5552 5560 (Pubitemid 43119350)
23. P.B. Vermeulen, G. Gasparini, and S.B. Fox Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours Eur J Cancer 38 2002 1564 1579 (Pubitemid 34876495)
24. G. Niu, T. Bowman, and M. Huang Roles of activated Src and Stat3 signaling in melanoma tumor cell growth Oncogene 21 2002 7001 7010 (Pubitemid 35252974)
25. R.J. Tomanek, A. Ratajska, G.T. Kitten, X. Yue, and A. Sandra Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis Dev Dyn 215 1999 54 61 (Pubitemid 29215703)
26. A.J. Naiyer, D.Y. Jo, and J. Ahn Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin Blood 94 1999 4011 4019
27. A.V. Kurtova, A.T. Tamayo, R.J. Ford, and J.A. Burger Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting Blood 113 2009 4604 4613
28. Y.K. Lee, N.D. Bone, A.K. Strege, T.D. Shanafelt, D.F. Jelinek, and N.E. Kay VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia Blood 104 2004 788 794 (Pubitemid 38970575)
29. K.J. Till, D.G. Spiller, and R.J. Harris CCL, but not normal B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium Blood 105 2005 4813 4819 (Pubitemid 40807308)
30. L. Smolej, C. Andrys, S. Pekova, J. Schwarz, D. Belada, and P. Zak Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia Haematologica 91 2006 1432 1433 (Pubitemid 44569828)
31. J.L. Frater, N.E. Kay, C.L. Goolsby, S.E. Crawford, G.W. Dewald, and L.C. Peterson Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence Diagn Pathol 3 2008 16
32. A.K. Ghosh, T.D. Shanafell, A. Cimmino, C. Taccioli, S. Volinia, and C.G. Liu Aberrant refulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells Blood 113 2009 5568 5574
33. J.E. Jung, H.S. Kim, and C.S. Lee STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination Exp Mol Med 40 2008 479 485 (Pubitemid 352789087)
34. J.E. Jung, H.G. Lee, and I.H. Cho STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells Faseb J 19 2005 1296 1298 (Pubitemid 41113728)
35. B.W. Long, P.L. Witte, G.N. Abraham, S.A. Gregory, and J.M. Plate Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells Proc Natl Acad Sci U S A 92 1995 1416 1420
36. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676 (Pubitemid 36749215)
37. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22 (Pubitemid 29038270)
38. M. Farahani, A.T. Treweeke, and C.H. Toh Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells Leukemia 19 2005 524 530 (Pubitemid 40521154)
39. Y.K. Lee, T.D. Shanafelt, N.D. Bone, A.K. Strege, D.F. Jelinek, and N.E. Kay VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance Leukemia 19 2005 513 523 (Pubitemid 40521153)
40. U. Schonbeck, and P. Libby The CD40/CD154 receptor/ligand dyad Cell Mol Life Sci 58 2001 4 43 (Pubitemid 32143961)
41. N.E. Kay, and B.T. Pittner IL-4 biology: impact on normal and leukemic CLL B cells Leuk Lymphoma 44 2003 897 903 (Pubitemid 36416984)